Iguana Healthcare Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Iguana Healthcare Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.06M	Buy	+27,500	New	+$3.29M	2.02%	17
2017 Q4	–	Sell	-40,000	Closed	-$5.61M	–	80
2017 Q3	$5.61M	Sell	40,000 -20,000	-33%	-$2.72M	3.06%	8
2017 Q2	$7.3M	Buy	60,000 +10,000	+20%	+$1.16M	4.13%	2
2017 Q1	$6.06M	Sell	50,000 -5,000	-9%	-$645K	3%	9
2016 Q4	$6.73M	Sell	55,000 -95,000	-63%	-$11.6M	4.02%	6
2016 Q3	$18.4M	Buy	150,000 +100,000	+200%	+$12.9M	3.28%	5
2016 Q2	$5.84M	Buy	+50,000	New	+$7.09M	2.37%	13
2014 Q3	–	Sell	-25,000	Closed	-$3.91M	–	84
2014 Q2	$3.91M	Buy	25,000 +5,000	+25%	+$789K	1.82%	21
2014 Q1	$3.04M	Buy	+20,000	New	+$3.18M	1.41%	28

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iguana Healthcare Management's ALXN Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Alexion Pharmaceuticals (ALXN) in Q1 2018: 27,500 shares worth $3.06M. The stake represents 2.02% of the portfolio and ranks #17 among its holdings. This is a return to the name: Iguana Healthcare Management previously reported a position in ALXN as recently as Q3 2017.

Iguana Healthcare Management first reported a position in ALXN in Q1 2014 and has held it in 9 quarters since. The position peaked at $18.4M in Q3 2016. 597 funds tracked by Wall St. Rank hold ALXN as of Q1 2018.

Iguana Healthcare Management held 27,500 shares of Alexion Pharmaceuticals worth $3.06M as of Q1 2018.
Alexion Pharmaceuticals was a new Iguana Healthcare Management position in Q1 2018.
Alexion Pharmaceuticals made up 2.02% of Iguana Healthcare Management's portfolio in Q1 2018, its #17 holding.
Iguana Healthcare Management first reported a position in Alexion Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
Iguana Healthcare Management's Alexion Pharmaceuticals position peaked at $18.4M in Q3 2016.
597 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.